These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 498154)
1. cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group. Thigpen T; Shingleton H; Homesley H; LaGasse L; Blessing J Cancer Treat Rep; 1979; 63(9-10):1549-55. PubMed ID: 498154 [TBL] [Abstract][Full Text] [Related]
2. Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group Study. Rossof AH; Talley RW; Stephens R; Thigpen T; Samson MK; Groppe C; Eyre HJ; Fisher R Cancer Treat Rep; 1979; 63(9-10):1557-64. PubMed ID: 498155 [TBL] [Abstract][Full Text] [Related]
3. Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study. Slayton RE; Creasman WT; Petty W; Bundy B; Blessing JA Cancer Treat Rep; 1979; 63(11-12):2089-92. PubMed ID: 526942 [No Abstract] [Full Text] [Related]
4. Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Thigpen JT; Blessing JA; Fowler WC; Hatch K Cancer Treat Rep; 1986 Sep; 70(9):1097-100. PubMed ID: 3755650 [TBL] [Abstract][Full Text] [Related]
5. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer. Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224 [TBL] [Abstract][Full Text] [Related]
6. Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study. Rossof AH; Coltman CA; Jones SE; Talley RW Cancer Treat Rep; 1979; 63(9-10):1605-8. PubMed ID: 498159 [TBL] [Abstract][Full Text] [Related]
7. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies. Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647 [TBL] [Abstract][Full Text] [Related]
8. Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary results. Cavalli F; Jungi WF; Sonntag RW; Nissen NI; Holland JF Cancer Treat Rep; 1979; 63(9-10):1599-603. PubMed ID: 227599 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group. Jobson VW; Muss HB; Thigpen JT; Homesley HD; Bundy B Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048 [TBL] [Abstract][Full Text] [Related]
10. cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study. Dombernowsky P; Sörenson S; Aisner J; Hansen HH Cancer Treat Rep; 1979 Apr; 63(4):543-5. PubMed ID: 221119 [No Abstract] [Full Text] [Related]
11. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. Rose PG; Blessing JA; Van Le L; Waggoner S Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702 [TBL] [Abstract][Full Text] [Related]
12. [Preliminary phase II study of cis-Dichlorodiammineplatinum (II) in patients with non-small cell carcinoma of the lung and metastatic pulmonary tumor]. Tominaga K; Saijo N; Eguchi K; Shinkai T; Shimizu E Gan No Rinsho; 1984 Sep; 30(11):1344-50. PubMed ID: 6094880 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas. Ajani JA; Ilson DH; Kelsen DP Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411 [TBL] [Abstract][Full Text] [Related]
14. Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital. Wiltshaw E; Subramarian S; Alexopoulos C; Barker GH Cancer Treat Rep; 1979; 63(9-10):1545-8. PubMed ID: 387225 [TBL] [Abstract][Full Text] [Related]
15. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix. Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125 [TBL] [Abstract][Full Text] [Related]
16. Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study. Nezhat F; Wadler S; Muggia F; Mandeli J; Goldberg G; Rahaman J; Runowicz C; Murgo AJ; Gardner GJ Gynecol Oncol; 2004 Apr; 93(1):144-8. PubMed ID: 15047228 [TBL] [Abstract][Full Text] [Related]
17. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary. Wiltshaw E; Kroner T Cancer Treat Rep; 1976 Jan; 60(1):55-60. PubMed ID: 1000519 [TBL] [Abstract][Full Text] [Related]
18. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients. Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378 [No Abstract] [Full Text] [Related]
19. Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy. Bruckner HW; Cohen CJ; Wallach RC; Kabakow B; Deppe G; Greenspan EM; Gusberg SB; Holland JF Cancer Treat Rep; 1978 Apr; 62(4):555-8. PubMed ID: 350392 [TBL] [Abstract][Full Text] [Related]
20. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group. Mannel RS; Blessing JA; Boike G Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]